FDA approves expanded label for Regeneron/Sanofi's Dupixent
The U.S. Food and Drug Administration on Wednesday approved Regeneron Pharmaceuticals Inc and Sanofi SA's drug Dupixent to treat nasal polyps, marking the third major use for the injectable medicine.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news